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by both TLR3 and TLR9 agonists (and
influenza virus) and which has also been
shown to stimulate CD4+ T cell-indepen-
dent priming of CTL responses (Le Bon
et al., 2003). Although type I IFN-stimu-
lated CD8+ T cell responses have been
shown to occur independently of CD40 in
the presence of CD4+ T cells, it’s possible
that this cytokine could trigger the
‘‘backup’’ pathway in the absence of
CD4+ cells. Thus, it may be of interest to
investigate the ability of type I IFN to
induce CD40L on DCs.
Finally, it will be important to determine
whether DC-expressed CD40L can affect
the function of CD40-expressing cells
other than CD8+ T cells. CD40 is constitu-
tively expressed on B cells and DCs
themselves, and the immunostimulatory
effects of triggering CD40 on these cells
are well recognized. In addition, CD40
can also be expressed by activated
CD4+ T cells (Bourgeois et al., 2002).
Given that activated CD8+ T cells can
express CD40L, there is the potential for
multiple levels of cellular crosstalk
involving CD40-CD40L interactions.
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In this issue of Immunity, Town et al. (2009) show the interplay between Toll-like receptors (TLRs) and cyto-
kines during West Nile virus infection and define a role for TLR-mediated production of interleukin-23 in
immune cell homing and pathogenesis.The endosomally located Toll-like recep-
tors (TLRs), notably TLR3, TLR7, TLR8,
and TLR9, are important in the host
response to viral nucleic acids. TLR7,
which is known to recognize single-
stranded RNA (ssRNA) viruses, and the
adaptor molecule MyD88, an essential
component of the response mediated by
all TLRs with the exception of TLR3, are
both important for viral containment. In
this issue of Immunity, Town et al. (2009)
present surprising evidence that the defi-
ciency of either TLR7 or MyD88 dramati-
cally affected leukocyte homing during
infection with the flavivirus West Nile virus
(WNV). By using an animal model to
address the specific role of TLR7 in
WNV infection, they found that mice lack-
ing TLR7 or MyD88 had increased
mortality and higher viral burdens thanthose of control mice. Immune cell
homing to the brain was also diminished
in WNV-infected animals deficient in
TLR7 and MyD88, specifically the infiltra-
tion by macrophages and CD4+ and
CD8+ T cells. To further explore themech-
anisms behind these findings, they exam-
ined systemic cytokine concentrations
in the infected mice. Surprisingly, the
amounts of the IL-12p40 (shared with
IL-23) subunit were substantially reduced
in TLR7-deficient mice, whereas type I
interferon, IL-6, and TNF concentrations
were not diminished. Because the p40
subunit is shared by both IL-12 and
IL-23, Town et al. used mice deficient in
individual subunits of IL-12 or IL-23 to
determine the specific role of each. Mice
deficient in IL-12p40 or IL-23p19, but
not IL-12p35, had decreased leukocyteImmunity 30homing to the brains and increased
mortality, supporting a unique role for IL-
23 in the generation of immune responses
following WNV infection.
These observations demonstrate the
dual roles of the innate immune system.
As in organisms without an adaptive
immune system, the proteins that make
up the innate immune systemofmammals
have a direct role in inducing the produc-
tion of antiviral substances like type I inter-
ferons (Figure 1) that prevent virus-
induced cell damage. At the same time,
however, these same TLRs can induce
the production of host cytokines that
affect the development of the acquired
immune response and may affect leuko-
cyte trafficking following WNV infection.
The role of TLR7 in the host response to
RNA viruses has been well documented., February 20, 2009 ª2009 Elsevier Inc. 173
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PreviewsFigure 1. Viral Recognition by Toll-like Receptors and RNA Helicases Leads to the
Production of Multiple Cytokines
Recognition of viral components by Toll-like receptors can occur at the cell surface, as with TLR2 and
TLR4, or in the endosome, as with TLR3, TLR7, TLR8, and TLR9. This can lead to the production of
type I interferons (IFNab), RANTES, or inflammatory cytokines such as IL-6, IL-8, or MCP-1. Production
of these cytokines is dependent on specific adaptor molecules such as Mal (or TIRAP) in the case of
TLR2 and TLR4, TRIF and TRAM in the case of TLR4, TRIF in the case of TLR3, and MyD88 in the case
of all TLRs except TLR3. Furthermore, the cytoplasmic RNA helicases RIG-I and MDA-5 can sense
double-stranded RNA (dsRNA) for the production of type I interferons. Town et al. demonstrate a key
role for TLR7 and MyD88 in the induction of IL-12 and IL-23 (blue arrow) and subsequent immune cell
homing during West Nile virus infection.Like WNV, the flavivirus dengue virus has
been shown to activate TLR7 (Wang et al.,
2006). Early investigations of viral interac-
tions with TLR7 utilized plasmacytoid
dendritic cells, which can produce robust
amounts of type I interferons after
engagement of TLR7 (Diebold et al.,
2004). However, TLR7’s role in the
production of inflammatory cytokines by
cells such as neutrophils (Wang et al.,
2008) has beenmore recently recognized.
Furthermore, there is a growing literature
supporting a role for MyD88 as a major
contributor to the adaptive immune
response to viruses. In the case of vesic-
ular stomatitis virus (VSV) infection in
mice, MyD88 is required for the develop-
ment of neutralizing antibody and the
generation of an adequate CD4+ T cell
response, given that mice deficient in
MyD88 develop lethal encephalitis as
a result of uncontrolled VSV (Zhou et al.,
2007). In the case of another ssRNA
virus, lymphocytic choriomeningitis virus
(LCMV), MyD88 is critical to the develop-
ment of both CD4+ and CD8+ responses
that result in viral clearance (Zhou et al.,174 Immunity 30, February 20, 2009 ª20092005, 2008b). Some of the effect of
MyD88 on the outcome of infection
relates to the importance of the MyD88-
mediated NF-kB activation pathway that
leads to the production of inflammatory
cytokines. The endosomal TLRs can
induce both type I interferons and inflam-
matory cytokines. TLR4, by virtue of its
dual activation pathway, also induces
both type I interferons and inflammatory
cytokines. In contrast, TLR2 is thought
to be mainly associated with induction of
inflammatory cytokines (Figure 1).
In this context, it is interesting to note
that TLR2 also has a role in the response
to LCMV. Microglial cells, resident cells
of the central nervous system (CNS) that
mediate neuroinflammation, produce
cytokines in response to LCMV in a
TLR2-dependent manner (Zhou et al.,
2008a). In vivo models have demon-
strated that the CNS cytokine induction
mediated through TLR3, in the case of
WNV, (Wang et al., 2004) or TLR2, in the
case of herpes simplex virus (HSV) (Kurt-
Jones et al., 2004), may lead to lethal
disease.Elsevier Inc.The findings presented by Town et al.
bring attention to several issues. Although
it is exciting that TLR7 can play a crucial
role in the recruitment of inflammatory
cells in the setting of CNS viral infection,
the TLR7-expressing cells that are, in
fact, responsible for this recruitment
remain undefined. Furthermore, a recur-
rent problem in understanding the
specific role of TLRs in vivo is that the
exact viral component that TLRs recog-
nize cannot always be clearly defined.
Here, the presumption is that the ssRNA
genome of WNV is being recognized in
the endosome of a TLR7-expressing
cell, but we do not know whether the cell
is native to the CNS or migrates there
from the bloodstream. A concern is that
both the cytoplasmic RNA sensors (RIG-I
and Mda-5) as well as the endosomal
TLRs are activated by foreign RNA
(Figure 1). Do they recognize the same
structures? If they recognize different
patterns, are the responses that are
mediated by these very different pattern
recognition proteins synergistic or antag-
onistic? We already know that different
cells express different sensors. How this
sorts out in vivo presumably defines the
pathogenic effects of the virus.
Given that treatment for WNV enceph-
alitis is currently limited to supportive
therapy, this study brings attention to
the concept of TLR agonists and/or
antagonists as potential therapeutic
agents for acute viral infections.
Because TLR7 may promote viral clear-
ance in an IL-23-dependent manner,
enhancement of this pathway by TLR7
agonists could be protective. In contrast,
TLR antagonists could prevent excess
CNS inflammation mediated by TLR3 in
the case of WNV encephalitis or by
TLR2 in the case of HSV-1 meningoen-
cephalitis.
In summary, the role of TLRs in viral
recognition by different cell populations
and the subsequent consequences on
leukocyte trafficking and viral control
in vivo have become increasingly under-
stood. The data presented by Town
et al. are unique for their demonstration
of the importance of TLR7 and IL-23 for
leukocyte homing following WNV infec-
tion in vivo. The concept that expression
of different TLRs on different cell popula-
tions may affect disease pathogenesis is
important. The mechanism by which
MyD88 and other TLRs affect adaptive
Immunity
Previewsimmune responses is one that is just
beginning to be elucidated.
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The two chief types of mature B cells
produced in adults are follicular and
marginal zone (MZ)Bcells.FollicularBcells
make up the bulk of peripheral B cells,
recirculate,andare themaincell type found
in the follicles of the splenic white pulp. In
contrast, MZ B cells are less abundant
and are actively retained within the MZ
located between the marginal sinus,
a main site for blood flow through the
spleen (Lu and Cyster, 2002; Pillai et al.,
2005), and the splenic red pulp. MZ B cells
play a pivotal role in host defense against
blood-borne bacterial pathogens, and
their localization near the blood-rich
marginal sinus is thought to be a key
component of this unique function (Pillai
et al., 2005).
One markedly incomplete puzzle for
B cell biologists is how immature B cells
are recruited into either the follicular or
the MZ B cell pools. Current data suggest
that this cell-fate decision is influenced by
a variety of extracellular inputs, including
signals derived from the B cell receptor
(BCR). A role for the BCR in the follicular
versus MZ B cell-fate decision is sup-
ported by experiments showing thatand Fikrig, E. (2009). Immunity 30, this issue,
242–253.
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h2 by Fringe enzymes is critical tom
newly formed B cells specific for certain
self antigens preferentially generate MZ
B cells (Martin and Kearney, 2000; Wen
et al., 2005), as well as by experiments
showing that mutation of the BCR
signaling machinery can markedly influ-
ence the follicular versus MZ B cell-fate
choice (Martin and Kearney, 2000).
MZ B cells are also unique among
B-lineage cells in that their propagation is
highly dependent on signals provided by
the Notch family of cell-surface receptors.
In mammals, the Notch family contains
four different receptors (Notch1–4) and at
least five different ligands, including three
members of the Delta-like (DL) family (DL1,
DL3, and DL4) and two members of the
Serrate family (Jagged-1 and Jagged-2)
(Maillard et al., 2005). Engagement of
Notch receptors by ligands activates the
proteolytic release of the intracellular
Notch domain (ICN) from the cell
membrane. Consequently, ICN migrates
to the nucleus, where it interacts with the
transcription factor CSL and the transcrip-
tional coactivator MAML1 to promote the
expression of a wide and largely unknown
collection of genes.
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In this issue of Immunity, Tan et al.
aturing B cells for accessing DL1 on
Interestingly, although Notch1-DL4
interactions regulate a variety of differ-
entiation events within the T cell lineage,
MZ B cell development specifically
requires Notch2 and DL1 (Hozumi
et al., 2004; Saito et al., 2003). Indeed,
mice lacking either Notch2 or DL1 fail
to generate MZ B cells but do not
exhibit defects in T cell development or
function. These findings raise several
fundamental questions about how,
when, and where immature peripheral
B cells are engaged by DL1 and whether
Notch2 is unique among Notch recep-
tors in its capacity for promoting MZ
B cell development.
In this issue of Immunity, Tan et al.
provide two much needed insights into
how immature B cells gain access to DL1
(Tan et al., 2009). First, they show that
optimal MZ B cell differentiation requires
modification of Notch2 by members of
the Fringe family of beta-1,3-N-acetylglu-
cosaminyltransferases. Second, and
perhaps especially surprising, they show
that constitutive DL1 expression in the
spleen is restricted to clusters of vascular
endothelial cells within the MZ and red
, February 20, 2009 ª2009 Elsevier Inc. 175
